Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
Filter
Search Result
Results for "

β amyloid (35 42)

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    4
    TargetMol | Peptide_Products
β-Amyloid (35-42)
β-Amyloid 35-42
TP1586183292-41-3
β-Amyloid (35-42), a peptide derived from the beta-amyloid protein, encompasses amino acids 35 through 42.
  • Inquiry Price
Size
QTY
(Met(O)35)-Amyloid β-Protein (1-42)
T76395
(Met(O)35)-Amyloid β-Protein (1-42) is the oxidized form of Methionine 35 in Aβ42, capable of producing an oligomer size distribution similar to Aβ40. This compound is utilized in Alzheimer's disease (AD) research [1].
  • Inquiry Price
Size
QTY
(Met(O2)35)-Amyloid β-Protein (1-42)
T76396
(Met(O2)35)-Amyloid β-Protein (1-42) is a peptide [1].
  • Inquiry Price
Size
QTY
Amyloid-β (25-35) Peptide (human) (trifluoroacetate salt)
T37370
Amyloid-β (25-35) (Aβ (25-35)) is an 11-residue fragment of the Aβ protein that retains the physical and biological characteristics of the full length peptide. It forms fibrils that react to thioflavin T and Congo red and are organized in a cross-β arrangement of β-strands similar to Aβ (1-40) and Aβ (1-42) fibrils. Aggregated Aβ (25-35) decreases the viability of rat adrenal PC12 cells. It also decreases the viability of primary rat cortical neurons at concentrations ranging from 1 nM to 30 μM. In vivo, intracerebral injection of Aβ (25-35) (20 nmol) in rats induces lesions of neuronal and tissue loss. Aggregated Aβ (25-35) administered intracerebroventricularly to rats induces learning and memory impairments in the Y-maze, novel object recognition, and contextual fear conditioning tests.
  • TBD
35 days
Size
QTY